N
DNA icon

Numerai’s Ginkgo Bioworks DNA Stock Holding History

Numerai’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Sell
104,602
-71,068
-40% -$594K 0.08% 390
2026
Q1 		$1.08M Buy
175,670
+150,045
+586% +$1.25M 0.11% 318
2025
Q4 		$213K Buy
25,625
+12,421
+94% +$134K 0.03% 573
2025
Q3 		$193K Buy
+13,204
New +$158K 0.03% 512
2024
Q3 		– Sell
-6,289
Closed -$84.1K – 383
2024
Q2 		$84.1K Buy
+6,289
New +$188K 0.03% 306

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Numerai's DNA Position: Q2 2026 in Review

Numerai reduced its Ginkgo Bioworks (DNA) stake by 40% in Q2 2026, selling an estimated $594K and leaving 104,602 shares worth $1.04M. The position accounts for 0.08% of the portfolio, ranked #390.

Numerai first reported a position in DNA in Q2 2024 and has held it in 5 quarters since. The position peaked at $1.08M in Q1 2026. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Numerai held 104,602 shares of Ginkgo Bioworks worth $1.04M as of Q2 2026.
  • Numerai sold 71,068 Ginkgo Bioworks shares in Q2 2026, an estimated $594K.
  • Ginkgo Bioworks made up 0.08% of Numerai's portfolio in Q2 2026, its #390 holding.
  • Numerai first reported a position in Ginkgo Bioworks in Q2 2024 and has held it in 5 quarters since.
  • Numerai's Ginkgo Bioworks position peaked at $1.08M in Q1 2026.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Numerai's 13F filing for Q2 2026, filed 14 Aug 2026.